Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
6 trials since 2013, 3 ongoing, by the sponsor of the products; see every authorized trial
Response: a placebo-controlled, randomized, phase 3 study to evaluate the safety and efficacy of seladelpar in patients…Mar 3, 2021 · Closed · Seladelpar (MBX-8025)
A phase 2, randomized, double blind, placebo controlled, multiple center study to evaluate the safety, tolerability,…Jul 24, 2019 · Ongoing · Seladelpar
A 52-week, placebo-controlled, randomized, phase 3 study to evaluate the safety and efficacy of seladelpar in subjects…Nov 1, 2018 · Closed · Seladelpar (MBX-8025)
A 12-week, double-blind, randomized, placebo-controlled, phase 2 study, to evaluate the effects of two doses of…Sep 16, 2015 · Ongoing · MBX-8025
A 12-week, open-label, dose-escalating, phase 2 study to evaluate the effects of MBX-8025 in patients with homozygous…May 15, 2015 · Closed · MBX-8025
A randomized, double-blind, active and placebo-controlled study to evaluate the efficacy and safety of arhalofenate for…Mar 3, 2014 · Ongoing · Arhalofenate (MBX-102)
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.